The D-type prostanoid (DP) receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) 
Methods
The cross-talk of CRTH2 and DP receptors was investigated using both a recombinant HEK293 cell model and human eosinophils in Ca 2+ mobilization assays, coimmunoprecipitation and radioligand binding assays.
Results
We show that CRTH2 and DP receptors modulate each other's signalling properties and form CRTH2/DP heteromers without altering their ligand-binding capacities. We find that the DP receptor amplifies the CRTH2-induced Ca 2+ release from intracellular stores and, coincidentally, forfeits its own signalling potency. Moreover, desensitization or pharmacological blockade of the DP receptor hinders CRTH2-mediated signal transduction. Pharmacological blockade of Gα q/11 proteins abolishes the Ca 2+ response to both CRTH2 and DP agonists, while inhibition of Gα i proteins selectively attenuates the CRTH2-mediated response but not the DP signal.
Conclusions
Our data demonstrate the capacity of DP receptors to amplify the biological response to CRTH2 activation. Therefore, the CRTH2/DP heteromer may not only represent a functional signalling unit for PGD 2 but also a potential target for development of heteromer-directed therapies to treat allergic diseases.
